Shardul Amarchand Mangaldas & Co. successfully represented Berhyanda Limited (a company controlled by funds managed by Advent International Corporation) (Acquirer) on its acquisition of majority shareholding of Suven Pharmaceuticals Limited (Suven / Target).   The transaction has been unconditionally approved by the Competition Commission of India on 20 April, 2023. The transaction is one of… Read More +

Shardul Amarchand Mangaldas & Co. advised Kotak Real Estate Fund X, a fund managed by Kotak Investment Advisors, in connection with its investment in the non- convertible debentures issued by Bharat Hotels Limited (“BHL”) (parent entity of the LaLiT Hospitality Group which owns and operates 13 luxury hotels, spa and resort properties in India). The… Read More +

Shardul Amarchand Mangaldas & Co. advised Aequs Private Limited (“Aequs”), a Belagavi-based contract manufacturing company, in relation to its Rs. 225 crore fund-raise from Amicus Capital. The SAM & Co team assisted Aequs on all the legal and regulatory aspects of the transaction, including structuring of the deal, undertaking due diligence as well as drafting,… Read More +